Volume 15, Number 5—May 2009
Molecular Epidemiology of Feline and Human Bartonella henselae Isolates
Multiple locus variable number tandem repeat analysis was performed on 178 Bartonella henselae isolates from 9 countries; 99 profiles were distributed into 2 groups. Human isolates/strains were placed into the second group. Genotype I and II isolates shared no common profile. All genotype I isolates clustered within group B. The evolutive implications are discussed.
Bartonella henselae is the zoonotic agent of cat-scratch disease and has been associated with bacillary angiomatosis, bacillary peliosis, endocarditis, osteomyelitis, and neuroretinitis (1). It is usually present in low numbers in infected human tissues, whereas cats, the natural reservoir for the bacterium, are prone to persistent bacteremia. Therefore, most B. henselae isolates are of feline origin. Two genotypes, based on 16S rDNA differences, have been described (1). Genotype I was more frequently observed in humans in some countries where most cats are infected with genotype II (2,3). Genotype II is more prevalent in cats in Europe, Australia, and the United States (2–6), and most feline isolates from Asia belong to genotype I (7–9). In a recent study, 3 (1.6%) of 191 B. henselae isolates harbored 2 different 16S rDNA copies and could not be assigned to a distinct genotype (10). However, most isolates harbored 2 identical 16S rDNA copies and were assigned to either type I or II, confirming that delineation of B. henselae isolates in two 16S rDNA types is generally reasonable.
Multiple-locus variable number tandem repeat analysis (MLVA) was recently developed for B. henselae typing (6). The results are produced in an intrinsically quantitative form, called a profile, corresponding to the number of basic units in an isolate for each variable number tandem repeat (VNTR). MLVA was more discriminatory (11) than the other widely used typing techniques, such as pulsed-field gel electrophoresis (2), multilocus sequence typing (MLST) (12) and multispacer typing (MST) (13). In our protocol, MLVA involves the amplification of 5 main VNTR loci, BHV-A to -E, for B. henselae VNTRs (6).
We analyzed 178 B. henselae isolates/strains from various sources (Table 1): 156 (88%) feline isolates/strains, 21 (11%) from diseased humans, and 1 isolate from a sick dog. The number of alleles varied from 7 (BHV-E) to 22 (BHV-B). Most of the European isolates (all but 1 of feline origin) (2,4,6) and of the American isolates/strains (North Carolina and California) (5,14), of which 85% were of feline origin, belonged to genotype II (89% and 64.6%, respectively). The Asian isolates (all but 1 of feline origin) (7–9) and the Australasian isolates (60% of human origin) (12), mainly belonged to genotype I (89.6% and 65%, respectively).
Ninety-nine different MLVA profiles were observed (Table 1), corresponding to an average number of isolates per profile of 1.8 (Table 2). Sixty-nine of these profiles were found in only 1 isolate or strain (67%), and 30 were observed in >1 isolate. Among these, none was shared by genotype I and genotype II isolates. Diversity index (DI) was 0.98 (Table 1). Diversity was observed in both genotypes because genotype-specific DIs were almost identical (Table 1).
MLVA profiles appeared location-specific because only 4 (13%) of the 30 profiles observed in >1 isolate/strain were present in >1 continent (Table 2). Within continents, no marked dominance of a given profile was observed, and continent-specific DIs were similar (Table 1).
Of the 99 B. henselae profiles, 12 were obtained from the 21 human isolates/strains and 1 from the dog, whereas 92 profiles were obtained from the 156 feline isolates. Five profiles were common to 5 human and 11 feline isolates. Among the 30 profiles observed in >2 isolates, 23 were observed only in feline isolates (Table 2). The proportion of genotype I profiles was significantly higher in human-specific profiles than in cat-specific profiles (p = 0.01, by Fisher test).
For BHV-A, only 2 alleles (14 and 15 copies) were found in isolates from humans, whereas all 8 identified alleles were observed in cat isolates. The number of repeats differed significantly between sick humans and healthy cats (p = 0.02, by Fisher test).
Relationships between the 99 MLVA profiles were analyzed by unweighted pair group method with arithmatic mean (UPGMA), using a categorical distance, with a B. koehlerae isolate used as an outgroup. To take into account that UPGMA is sensitive to taxa entry order, we computed the majority-rule consensus tree of 500 dendrograms built with random taxa entry order. MLVA profiles were grouped into 2 main groups named A and B (Appendix Figure). Group A (26 profiles), was exclusively constituted by genotype II feline isolates. Group B (73 profiles), to which all human isolates belonged, further divided in 2 subgroups, Ba and Bb. Subgroup Ba (38 profiles) was exclusively composed of genotype I isolates, including the reference strain Houston I and a homogenous subgroup, Ba1, containing 84% of the Asian isolates. Finally, 83% of subgroup Bb isolates belonged to genotype II (29/35 profiles).
The utility of MLVA for molecular epidemiologic analysis of clusters was tested using isolates from California cats and their owners (14). Five human–cat groups of B. henselae isolates were analyzed. For 1 cat-human pair of isolates, which belonged, respectively, to genotype II and genotype I, major profile differences were observed, as expected. The 4 other cat-human groups, which possessed the same genotype, also had the same MLVA profile with the 5 tested BHV, as well as with the 6 additional BHV (F–K) and variant alleles for BHV-A and/or B (6). Sequencing confirmed these results.
Our results confirm that VNTRs are excellent molecular markers for confirming or excluding the responsibility of a given cat in the transmission of B. henselae to a human. In California, the profile identity observed within 4 clusters further supports the hypothesis that all these humans acquired infection from their respective domestic cat contacts.
MLVA enabled a clear separation between genotypes I and II, because no profile was shared between both genotypes. The dendrogram showed a high level of discrimination between 16S rDNA genotypes in the B. henselae population tested. Interestingly, the groups and subgroups delineated by MLVA were the same as those defined by MLST, a standard method for phylogenetic analysis (12). The same was observed with MST (13). The isolates of the subgroup Bb appeared divergent and distant from each other and from subgroup Ba that contains almost all genotype I profiles (98%). Moreover and despite possible clustering for some of the isolates, none of the 21 human isolates was present in group A. Interestingly, as for most of the human patients, the isolate obtained from the ill dog also belonged to genotype I.
These observations suggest that all genotype I isolates could be phylogenetically derived from genotype II isolates located in group B but not in group A, as already suggested using MLST (15). This observation could mean that genotype II isolates belonging to group B are closer to genotype I isolates than to genotype II isolates belonging to group A; it also raises an important clinical question: Are feline genotype II isolates belonging to group A nonpathogenic for humans? Genotype I isolates could represent the most pathogenic isolates for humans within a group of potentially zoonotic isolates, all belonging to group B and could represent an ultimate evolutionary step toward human infection. Additionally, within group B, the differences in the number of BHV-A repeat units observed between isolates from patients (humans, dog) versus cat isolates suggest that this specific VNTR could constitute a marker for the ability to cross the species barrier from reservoir cats to susceptible species, independent of the 16S rDNA genotype.
Ms Bouchouicha is a third-year doctoral student at the Unité Mixte de Recherche, Biologie Moléculaire et Immunologie Parasitaires et Fongiques, Maison-Alfort, France. Her research interests focus on the molecular epidemiology of animal diseases and zoonoses.
We thank Dorsey Kordick for providing cat isolates from North Carolina.
This work was supported by a grant from the Merial Company (grant no. 02TIC), National Institutes of Health grant R01 AI52813, a CA HIV/AIDS Research Program Award, and a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research.
- Boulouis HJ, Chang CC, Henn JB, Kasten RW, Chomel BB. Factors associated with the rapid emergence of zoonotic Bartonella infections. Vet Res. 2005;36:383–410.
- Arvand M, Klose AJ, Schwartz-Porsche D, Hahn H, Wendt C. Genetic variability and prevalence of Bartonella henselae in cats in Berlin, Germany, and analysis of its genetic relatedness to a strain from Berlin that is pathogenic for humans. J Clin Microbiol. 2001;39:743–6.
- Dillon B, Valenzuela J, Don R, Blanckenberg D, Wigney DI, Malik R, Limited diversity among human isolates of Bartonella henselae. J Clin Microbiol. 2002;40:4691–9.
- Birtles RJ, Layccock G, Kenny MJ, Shaw SE, Day MJ. Prevalence of Bartonella species causing bacteraemia in domesticated and companion animals in the United Kingdom. Vet Rec. 2002;151:225–9.
- Chomel BB, Abbott RC, Kasten RW, Floyd-Hawkins KA, Kass PH, Glaser CA, et al. Bartonella henselae prevalence in domestic cats in California: risk factors and association between bacteremia and antibody titers. J Clin Microbiol. 1995;33:2445–50.
- Monteil M, Durand B, Bouchouicha R, Petit E, Chomel B, Arvand M, Development of discriminatory multiple-locus variable-number tandem repeat analysis for Bartonella henselae Microbiol. 2007;153:1141–8.
- Maruyama S, Nakamura Y, Kabeya H, Tanaka S, Sakai T, Katsube Y. Prevalence of Bartonella henselae, Bartonella clarridgeiae and the 16S rRNA gene types of Bartonella henselae among pet cats in Japan. J Vet Med Sci. 2000;62:273–9.
- Chomel BB, Carlos ET, Kasten RW, Yamamoto K, Chang CC, Carlos RS, Bartonella henselae and Bartonella clarridgeiae infection in domestic cats from the Philippines. Am J Trop Med Hyg. 1999;60:593–7.
- Maruyama S, Sakai T, Morita Y, Tanaka S, Kabeya H, Boonmar S, Prevalence of Bartonella species and 16S rRNA gene types of Bartonella henselae from domestic cats in Thailand. Am J Trop Med Hyg. 2001;65:783–7.
- Viezens J, Arvand M. Simultaneous presence of two different copies of the 16S rRNA gene in Bartonella henselae. Microbiology. 2008;154:2881–6.
- Bouchouicha R, Boulouis H-J, Berrich M, Monteil M, Chomel B, Haddad N. Comparison of the performances of MLVA versus the main other typing techniques for Bartonella henselae. Clin Microbiol Infect. In press.
- Iredell J, Blanckenberg D, Arvand M, Grauling S, Feil EJ, Birtles RJ. Characterization of the natural population of Bartonella henselae by multilocus sequence typing. J Clin Microbiol. 2003;41:5071–9.
- Li W, Raoult D, Fournier PE. Genetic diversity of Bartonella henselae in human infection detected with multispacer typing. Emerg Infect Dis. 2007;13:1178–83.
- Chang CC, Chomel BB, Kasten RW, Tappero JW, Sanchez MA, Koehler JE. Molecular epidemiology of Bartonella henselae infection in human immunodeficiency virus-infected patients and their cat contacts, using pulsed-field gel electrophoresis and genotyping. J Infect Dis. 2002;186:1733–9.
- Arvand M, Feil EJ, Giladi M, Boulouis HJ, Viezens J. Multi-locus sequence typing of Bartonella henselae isolates from three continents reveals hypervirulent and feline-associated clones. PLoS One. 2007;2:e1346.
Suggested citation for this article: Bouchouicha R, Durand B, Monteil M, Chomel BB, Berrich M, Arvand M, et al. Molecular epidemiology of feline and human Bartonella henselae isolates. Emerg Infect Dis [serial on the Internet]. 2009 May [date cited]. Available from http://wwwnc.cdc.gov/eid/article/15/5/08-0995
Comments to the Authors
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: December 20, 2010
- Page last updated: December 20, 2010
- Page last reviewed: December 20, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)